SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...
Quidel Corporation QDEL recently entered into a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc OCDX. The transaction, which is subject to approval of both the companies’ ...
We believe that the stock price of Quidel (NASDAQ:QDEL), a clinical genetic testing company, looks undervalued at current levels near $108. QDEL stock is actually up just 22% from levels of around $88 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results